Danske Bank A S purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 299,722 shares of the company’s stock, valued at approximately $116,859,000. Danske Bank A S owned 0.14% of HCA Healthcare at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in the company. Sumitomo Life Insurance Co. grew its holdings in HCA Healthcare by 1.0% during the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock worth $946,000 after acquiring an additional 20 shares in the last quarter. MJP Associates Inc. ADV lifted its position in shares of HCA Healthcare by 2.9% during the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after purchasing an additional 21 shares during the last quarter. Cary Street Partners Investment Advisory LLC increased its holdings in HCA Healthcare by 7.5% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock valued at $140,000 after buying an additional 21 shares during the last quarter. Anchyra Partners LLC lifted its holdings in HCA Healthcare by 3.7% during the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock worth $278,000 after buying an additional 21 shares during the last quarter. Finally, Plato Investment Management Ltd increased its holdings in shares of HCA Healthcare by 0.6% in the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock valued at $1,833,000 after acquiring an additional 22 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.
Wall Street Analyst Weigh In
HCA has been the subject of a number of research analyst reports. The Goldman Sachs Group lowered their price target on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating for the company in a report on Tuesday, July 28th. Truist Financial lowered their target price on shares of HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a report on Monday, July 27th. Oppenheimer cut their price target on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a research note on Monday, July 27th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $435.00 price objective on shares of HCA Healthcare in a report on Monday, July 27th. Finally, Raymond James Financial set a $528.00 target price on HCA Healthcare in a research report on Tuesday, July 7th. Fourteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and an average target price of $465.59.
HCA Healthcare Stock Performance
Shares of HCA Healthcare stock opened at $412.27 on Wednesday. HCA Healthcare, Inc. has a 1 year low of $353.99 and a 1 year high of $556.52. The company has a market capitalization of $89.26 billion, a P/E ratio of 13.80, a PEG ratio of 1.40 and a beta of 1.10. The company’s fifty day moving average is $395.07 and its two-hundred day moving average is $445.35.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The firm had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business’s revenue was up 8.7% on a year-over-year basis. During the same quarter last year, the company posted $6.84 earnings per share. As a group, equities analysts expect that HCA Healthcare, Inc. will post 29.47 earnings per share for the current year.
HCA Healthcare Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be issued a dividend of $0.78 per share. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.45%.
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Featured Articles
- Five stocks we like better than HCA Healthcare
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
